The formulation of nanomedicines for treating tuberculosis

Hydrogel: Preparation, characterization, and applications: A review

Ahmed, E. M. (2015) · Journal of Advanced Research · doi:10.1016/j.jare.2013.07.006 · Cited by 5,800 · see citing works

Mechanisms of phagocytosis in macrophages

Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854 · see citing works

Nanomedicine: current status and future prospects

Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029 · see citing works

Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues

Lai, S. K., Wang, Y.-Y., & Hanes, J. S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,827 · see citing works

Diagnostic Standards and Classification of Tuberculosis in Adults and Children: This Official Statement of the American Thoracic Society and the Centers for Disease Control and Prevention was Adopted by the ATS Board of Directors, July 1999. This Statement was endorsed by the Council of the Infectious Disease Society of America, September 1999

(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.16141 · Cited by 1,524 · see citing works

Nanogels as Pharmaceutical Carriers: Finite Networks of Infinite Capabilities

Kabanov, A. V., & Vinogradov, S. V. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900441 · Cited by 1,320 · see citing works

RESPONSE OF CULTURED MACROPHAGES TO MYCOBACTERIUM TUBERCULOSIS , WITH OBSERVATIONS ON FUSION OF LYSOSOMES WITH PHAGOSOMES

Armstrong, J. A., & Hart, P. D. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.134.3.713 · Cited by 991 · see citing works

Administration of substances to laboratory animals: routes of administration and factors to consider.

Turner, P. V., Brabb, T., Pekow, C. A., & Vasbinder, M. A. (2011) · PubMed Central · Cited by 982 · see citing works

A Periciliary Brush Promotes the Lung Health by Separating the Mucus Layer from Airway Epithelia

Button, B. M., Cai, L.-H., Ehré, C., Kesımer, M., Hill, D. B., Sheehan, J. K., Boucher, R. C., & Rubinstein, M. (2012) · Science · doi:10.1126/science.1223012 · Cited by 864 · see citing works

Mesoporous silica nanoparticles in medicine—Recent advances

Mamaeva, V., Sahlgren, C., & Lindén, M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.018 · Cited by 709 · see citing works

Particle Engineering for Pulmonary Drug Delivery

Chow, A. H. L., Tong, H. H. Y., Chattopadhyay, P., & Shekunov, B. Y. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9174-3 · Cited by 646 · see citing works

Nanoparticles for drug delivery to the lungs

Sung, J. C., Pulliam, B., & Edwards, D. A. (2007) · Trends in biotechnology · doi:10.1016/j.tibtech.2007.09.005 · Cited by 644 · see citing works

Diagnosis and Treatment of Extrapulmonary Tuberculosis

Lee, J. Y. (2015) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2015.78.2.47 · Cited by 519 · see citing works

Recent advances in hydrogel based drug delivery systems for the human body

Vashist, A., Vashist, A., Gupta, Y. K., & Ahmad, S. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb21016b · Cited by 499 · see citing works

Microencapsulated chitosan nanoparticles for lung protein delivery

Grenha, A., Seijo, B., & Remuñán‐López, C. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.04.009 · Cited by 469 · see citing works

Host–pathogen coevolution in human tuberculosis

Gagneux, S. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0316 · Cited by 413 · see citing works

The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells

Dartois, V. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3200 · Cited by 392 · see citing works

Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis

Pandey, R. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg477 · Cited by 389 · see citing works

Targeted delivery of magnetic aerosol droplets to the lung

Dames, P., Gleich, B., Flemmer, A. W., Hajek, K., Seidl, N., Wiekhorst, F., Eberbeck, D., Bittmann, I., Bergemann, C., Weyh, T., et al. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.217 · Cited by 382 · see citing works

Drug nanocrystals: in vivo performances.

Gao, L., Liu, G., Ma, J., Wang, X., Zhou, L., & Li, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.013 · Cited by 347 · see citing works

Tuberculosis: A disease without boundaries

Fogel, N. (2015) · Tuberculosis · doi:10.1016/j.tube.2015.05.017 · Cited by 333 · see citing works

Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis

Pandey, R., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2004.11.003 · Cited by 318 · see citing works

Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis

Zahoor, A., Sharma, S., & Khuller, G. K. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.07.012 · Cited by 314 · see citing works

Factors affecting drug encapsulation and stability of lipid–polymer hybrid nanoparticles

Cheow, W. S., & Hadinoto, K. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.02.033 · Cited by 298 · see citing works

Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance

Bosquillon, C., Lombry, C., Véronique Préat, A., & Rita Vanbever, A. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00362-x · Cited by 296 · see citing works

Advancing host-directed therapy for tuberculosis

Wallis, R. S., & Hafner, R. (2015) · Nature Reviews Immunology · doi:10.1038/nri3813 · Cited by 291 · see citing works

A 2020 vision for vaccines against HIV, tuberculosis and malaria

Rappuoli, R., & Aderem, A. A. (2011) · Nature · doi:10.1038/nature10124 · Cited by 274 · see citing works

Oral solid lipid nanoparticle-based antitubercular chemotherapy

Pandey, R., Sharma, S., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2005.08.009 · Cited by 271 · see citing works

Biodegradable polymeric nanocarriers for pulmonary drug delivery

Rytting, E., Nguyen, J., Wang, X., & Kissel, T. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.6.629 · Cited by 266 · see citing works

New old challenges in tuberculosis: Potentially effective nanotechnologies in drug delivery

Sosnik, A., Carcaboso, A. M., Glisoni, R. J., Moretton, M. A., & Chiappetta, D. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.023 · Cited by 264 · see citing works

Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages

Vyas, S. P., Kannan, M., Jain, S., Mishra, V. K., & Singh, P. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.08.017 · Cited by 262 · see citing works

Targeted Intracellular Delivery of Antituberculosis Drugs to Mycobacterium tuberculosis-Infected Macrophages via Functionalized Mesoporous Silica Nanoparticles

Clemens, D. L., Lee, B.-Y., Xue, M., Thomas, C. R., Meng, H., Ferris, D., Nel, A. E., Zink, J. I., & Horwitz, M. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06049-11 · Cited by 260 · see citing works

Liposomes: the Babraham connection

Bangham, A. D. (1993) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(93)90071-a · Cited by 260 · see citing works

In Vitro Structural and Functional Evaluation of Gold Nanoparticles Conjugated Antibiotics

Saha, B., Bhattacharya, J., Mukherjee, A., Ghosh, A., Santra, C. R., Dasgupta, A. K., & Karmakar, P. (2007) · Nanoscale Research Letters · doi:10.1007/s11671-007-9104-2 · Cited by 254 · see citing works

Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis

Sharma, A., Sharma, S., & Khuller, G. K. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh411 · Cited by 251 · see citing works

Formulation and Pharmacokinetics of Self-Assembled Rifampicin Nanoparticle Systems for Pulmonary Delivery

Sung, J. C., Padilla, D. J., Garcia‐Contreras, L., VerBerkmoes, J. L., Durbin, D., Peloquin, C. A., Elbert, K. J., Hickey, A. J., & Edwards, D. A. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9894-2 · Cited by 245 · see citing works

Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases

Andrade, F., Rafael, D., Videira, M., Ferreira, D., Sosnik, A., & Sarmento, B. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.020 · Cited by 245 · see citing works

Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential.

Ahmad, Z., Pandey, R., Sharma, S., & Khuller, G. K. (2006) · PubMed · Cited by 231 · see citing works

Ciprofloxacin-Protected Gold Nanoparticles

Tom, R. T., Suryanarayanan, V., Reddy, P. G., Baskaran, S., & Pradeep, T. (2004) · Langmuir · doi:10.1021/la0358567 · Cited by 231 · see citing works

Cutaneous tuberculosis overview and current treatment regimens

van Zyl, L., du Plessis, J., & Viljoen, J. M. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.12.006 · Cited by 230 · see citing works

Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies

Zumla, A. I., Chakaya, J. M., Centis, R., D’Ambrosio, L., Mwaba, P., Bates, M., Kapata, N., Nyirenda, T. E., Chanda, D. M., Mfinanga, S., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00063-6 · Cited by 221 · see citing works

Tuberculosis chemotherapy: current drug delivery approaches

du Toit, L. C., Pillay, V., & Danckwerts, M. P. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-118 · Cited by 213 · see citing works

Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles

Videira, M. A., Botelho, M. F., Santos, A. C., Gouveia, L. F., Pedroso de Lima, J. J., & Almeida, A. J. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000054933 · Cited by 213 · see citing works

Controlled pulmonary drug and gene delivery using polymeric nano-carriers

Beck-Broichsitter, M., Merkel, O. M., & Kissel, T. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.004 · Cited by 200 · see citing works

Cutaneous tuberculosis: epidemiologic, etiopathogenic and clinical aspects - Part I

dos Santos, J. B., Figueiredo, A. R., Ferraz, C., de Oliveira, M. H., da Silva, P. G., & de Medeiros, V. L. S. (2014) · Anais Brasileiros de Dermatologia · doi:10.1590/abd1806-4841.20142334 · Cited by 195 · see citing works

Current Concepts in the Management of Tuberculosis

Sia, I. G., & Wieland, M. L. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0820 · Cited by 193 · see citing works

Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification

Chono, S., Tanino, T., Seki, T., & Morimoto, K. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.1.0010 · Cited by 190 · see citing works

Antitubercular inhaled therapy: opportunities, progress and challenges

Pandey, R., & Khuller, G. K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki027 · Cited by 188 · see citing works

Pulmonary drug delivery systems for tuberculosis treatment

Pham, D.-D., Fattal, E., & Tsapis, N. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.009 · Cited by 185 · see citing works

Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages

Lee, W., Loo, C., Traini, D., & Young, P. M. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1039509 · Cited by 181 · see citing works

Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazid

Hearn, M. J., Cynamon, M. H., Chen, M. F., Coppins, R., Davis, J., Kang, H. J.-O., Noble, A., Tu‐Sekine, B., Terrot, M. S., & Trombino, D. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.05.009 · Cited by 181 · see citing works

Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model

Roa, W., Azarmi, S., Alhallak, K., Finlay, W. H., Magliocco, A. M., & Löbenberg, R. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.035 · Cited by 181 · see citing works

The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis

Krishnan, N., Robertson, B. D., & Thwaites, G. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.08.005 · Cited by 178 · see citing works

New perspectives in nanomedicine

Thorley, A. J., & Tetley, T. D. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.06.008 · Cited by 171 · see citing works

Inhaled drug therapy for treatment of tuberculosis

Misra, A., Hickey, A. J., Rossi, C. R., Borchard, G., Terada, H., Makino, K., Fourie, P. B., & Colombo, P. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.08.009 · Cited by 171 · see citing works

Nanobead-based interventions for the treatment and prevention of tuberculosis

Griffiths, G., Nyström, B., Sable, S. B., & Khuller, G. K. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2437 · Cited by 164 · see citing works

Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats

Wijagkanalan, W., Kawakami, S., Takenaga, M., Igarashi, R., Yamashita, F., & Hashida, M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.011 · Cited by 159 · see citing works

Comparison of ciprofloxacin hydrochloride‐loaded protein, lipid, and chitosan nanoparticles for drug delivery

Jain, D., & Banerjee, R. (2008) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.30994 · Cited by 158 · see citing works

Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery

Willis, L., Hayes, D., & Mansour, H. M. (2012) · Lung · doi:10.1007/s00408-011-9360-x · Cited by 148 · see citing works

Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles

Esmaeili, F., Hosseini-Nasr, M., Rad‐Malekshahi, M., Samadi, N., Atyabi, F., & Dinarvand, R. (2007) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2007.03.003 · Cited by 147 · see citing works

Inhaled Drug Delivery for Tuberculosis Therapy

Muttil, P., Wang, C., & Hickey, A. J. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9957-4 · Cited by 145 · see citing works

Mannan-Modified Solid Lipid Nanoparticles for Targeted Gene Delivery to Alveolar Macrophages

Yu, W., Liu, C., Liu, Y., Zhang, N., & Xu, W. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0149-z · Cited by 137 · see citing works

Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting

Nimje, N., Agarwal, A., Saraogi, G. K., Lariya, N., Rai, G., Agrawal, H., & Agrawal, G. P. (2009) · Journal of Drug Targeting · doi:10.3109/10611860903115308 · Cited by 137 · see citing works

Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid

Pourshahab, P. S., Gilani, K., Moazeni, E., Eslahi, H., Fazeli, M. R., & Jamalifar, H. (2011) · Journal of Microencapsulation · doi:10.3109/02652048.2011.599437 · Cited by 132 · see citing works

Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice

Deol, P., Khuller, G. K., & Joshi, K. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1211 · Cited by 128 · see citing works

Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects

Ain, Q. U. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg165 · Cited by 124 · see citing works

Respirable nanocarriers as a promising strategy for antitubercular drug delivery

Mehanna, M. M., Mohyeldin, S. M., & Elgindy, N. A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.038 · Cited by 119 · see citing works

Nanoparticles: Characteristics, Mechanisms of Action, and Toxicity in Pulmonary Drug Delivery—A Review

Gill, S., Löbenberg, R., Ku, T., Azarmi, S., Roa, W., & Prenner, E. J. (2007) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2007.015 · Cited by 118 · see citing works

New drugs for the treatment of tuberculosis: hope and reality [State of the Art Series. New tools. Number 2 in the series]

Grosset, J. H. E., Singer, T. G., & Bishai, W. R. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0277 · Cited by 118 · see citing works

Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis

Saraogi, G. K., Sharma, B., Joshi, B., Gupta, P., Gupta, U. D., Jain, N. K., & Agrawal, G. P. (2010) · Journal of drug targeting · doi:10.3109/1061186x.2010.492522 · Cited by 116 · see citing works

Liposomes as Drug Delivery Systems for The Treatment of TB

Pinheiro, M., Lúcio, M., Lima, J. L. F. C., & Reis, S. (2011) · Nanomedicine · doi:10.2217/nnm.11.122 · Cited by 115 · see citing works

Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers

Pandey, R. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh139 · Cited by 110 · see citing works

Enhanced rifampicin delivery to alveolar macrophages by solid lipid nanoparticles

Chuan, J., Li, Y., Yang, L., Sun, X., Zhang, Q., Gong, T., & Zhang, Z. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-1634-1 · Cited by 107 · see citing works

A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics

Chan, J. G. Y., Chan, H., Prestidge, C. A., Denman, J. A., Young, P. M., & Traini, D. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.08.007 · Cited by 100 · see citing works

Current status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosis

Ahmad, S., & Mokaddas, E. M. (2013) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2013.09.001 · Cited by 98 · see citing works

A novel approach for lung delivery of rifampicin-loaded liposomes in dry powder form for the treatment of tuberculosis

Patil, J., Devi, V., Devi, K., & Sarasija, S. (2015) · Lung India · doi:10.4103/0970-2113.159559 · Cited by 98 · see citing works

Encapsulation of Rifampicin in a solid lipid nanoparticulate system to limit its degradation and interaction with Isoniazid at acidic pH

Singh, H., Bhandari, R., & Kaur, I. P. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.012 · Cited by 91 · see citing works

Enhancing encapsulation efficiency of highly water-soluble antibiotic in poly(lactic-co-glycolic acid) nanoparticles: Modifications of standard nanoparticle preparation methods

Cheow, W. S., & Hadinoto, K. (2010) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2010.08.050 · Cited by 89 · see citing works

Present status of nanoparticle research for treatment of Tuberculosis

Shegokar, R., Shaal, L. A., & Mitri, K. (2011) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3m59p · Cited by 87 · see citing works

Effervescent dry powder for respiratory drug delivery

Ely, L., Roa, W., Finlay, W. H., & Löbenberg, R. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.10.021 · Cited by 86 · see citing works

Association of the anti-tuberculosis drug rifampicin with a PAMAM dendrimer

Bellini, R. G., Guimarães, A. P., Pacheco, M. A. C., Dias, D. M., Rodrigues-Furtado, V. L., de Alencastro, R. B., & Horta, B. A. C. (2015) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2015.05.012 · Cited by 85 · see citing works

Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis

Garg, T., Rath, G., & Goyal, A. K. (2015) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2015.1008508 · Cited by 84 · see citing works

Single step spray drying method to develop proliposomes for inhalation: A systematic study based on quality by design approach

Patil-Gadhe, A., & Pokharkar, V. (2013) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2013.07.006 · Cited by 83 · see citing works

Rifampicin Loaded Mannosylated Cationic Nanostructured Lipid Carriers for Alveolar Macrophage-specific Delivery

Song, X. C., Lin, Q., Guo, L. H., Fu, Y. S., Han, J., Ke, H., Sun, X., Gong, T., & Zhang, Z. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1572-3 · Cited by 82 · see citing works

Tuberculosis drug development: Progress, challenges, and the road ahead

Ginsberg, A. M. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.03.003 · Cited by 82 · see citing works

Pharmacokinetic Factors in the Modern Drug Treatment of Tuberculosis

Douglas, J. G., & McLeod, M. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937020-00003 · Cited by 82 · see citing works

Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice

Agarwal, A., Kandpal, H., Gupta, H. P., Singh, N. B., & Gupta, C. M. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.588 · Cited by 81 · see citing works

Incorporation of Antibiotics in Liposomes Designed for Tuberculosis Therapy by Inhalation

Justo, O. R., & Moraes, Â. M. (2003) · Drug Delivery · doi:10.1080/713840401 · Cited by 77 · see citing works

A new respirable form of rifampicin

Son, Y., & McConville, J. T. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.02.004 · Cited by 73 · see citing works

Cutaneous Tuberculosis in Children

Sethuraman, G., & Ramesh, V. (2012) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2012.01794.x · Cited by 72 · see citing works

Vaccination against tuberculosis: How can we better BCG?

Pitt, J. M., Blankley, S., McShane, H., & O’Garra, A. (2012) · Microbial Pathogenesis · doi:10.1016/j.micpath.2012.12.002 · Cited by 71 · see citing works

Model Answers to Lipid Membrane QuestionsPreprint

Mouritsen, O. G. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004622 · Cited by 69 · see citing works

The near future: Improving the activity of rifamycins and pyrazinamide

Mitchison, D. A., & Fourie, P. B. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.03.005 · Cited by 68 · see citing works

The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?

Martı́n, C. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00109904 · Cited by 68 · see citing works

Nanomedicine and experimental tuberculosis: facts, flaws, and future

Pandey, R., & Ahmad, Z. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.01.009 · Cited by 66 · see citing works

In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid

Booysen, L., Kalombo, L., Brooks, E. J., Hansen, R. J., Gilliland, J. C., Gruppo, V., Lungenhofer, P., Semete‐Makokotlela, B., Swai, H., Kotzé, A. F., et al. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.01.038 · Cited by 65 · see citing works

Mannosylated liposomes for targeted gene delivery

Kong, F., Zhou, Ge, G., Liu, Wang, & Zhou (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29183 · Cited by 64 · see citing works

Airway surface liquid depth measured in ex vivo fragments of pig and human trachea: dependence on Na+ and Cl− channel function

Song, Y., Namkung, W., Nielson, D. W., Lee, J. W., Finkbeiner, W. E., & Verkman, A. S. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00085.2009 · Cited by 64 · see citing works

Cell Response to the Exposure to Chitosan–TPP//Alginate Nanogels

Schütz, C. A., Juillerat‐Jeanneret, L., Käuper, P., & Wandrey, C. (2011) · Biomacromolecules · doi:10.1021/bm201231x · Cited by 64 · see citing works

Osmotically regulated asymmetric capsular systems for simultaneous sustained delivery of anti-tubercular drugs

Prabakaran, D. S., Singh, P., Jaganathan, K. S., & Vyas, S. P. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.11.013 · Cited by 62 · see citing works

Magnetically mediated release of ciprofloxacin from polyvinyl alcohol based superparamagnetic nanocomposites

Bajpai, A. K., & Gupta, R. (2010) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-010-4214-2 · Cited by 58 · see citing works

Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers

Choonara, Y. E., Pillay, V., Ndesendo, V. M. K., du Toit, L. C., Kumar, P., Khan, R., Murphy, C. S., & Jarvis, D.-L. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.05.025 · Cited by 56 · see citing works

Novel pH- and Temperature-Responsive Blend Hydrogel Microspheres of Sodium Alginate and PNIPAAm-g-GG for Controlled Release of Isoniazid

Kajjari, P. B., Manjeshwar, L. S., & Aminabhavi, T. M. (2012) · AAPS PharmSciTech · doi:10.1208/s12249-012-9838-8 · Cited by 55 · see citing works

Stopping tuberculosis in the 21st century: Goals and strategies

Onozaki, I., & Raviglione, M. C. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01673.x · Cited by 54 · see citing works

A facile method of delivery of liposomes by nebulization

Desai, T. R., Hancock, R. E. W., & Finlay, W. H. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00264-x · Cited by 54 · see citing works

The behavior of PLGA microspheres containing rifampicin in alveolar macrophages

Onoshita, T., Shimizu, Y., Yamaya, N., Miyazaki, M., Yokoyama, M., Fujiwara, N., Nakajima, T., Makino, K., Terada, H., & Haga, M. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2009.10.036 · Cited by 54 · see citing works

Effect of PEGylation on the Stability of Liposomes During Nebulisation and in Lung Surfactant

Anabousi, S., Kleemann, E., Bakowsky, U., Kissel, T., Schmehl, T., Gessler, T., Seeger, W., Lehr, C., & Ehrhardt, C. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.461 · Cited by 54 · see citing works

An Isoniazid Analogue Promotes Mycobacterium tuberculosis-Nanoparticle Interactions and Enhances Bacterial Killing by Macrophages

de Faria, T. J., Roman, M., de Souza, N. M., Vecchi, R. D., de Assis, J. V., dos Santos, A. L. G., Bechtold, I. H., Winter, N., Soares, M. J., Silva, L. P., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05993-11 · Cited by 53 · see citing works

The role of particle physico-chemical properties in pulmonary drug delivery for tuberculosis therapy

Mortensen, N. P., Durham, P., & Hickey, A. J. (2014) · Journal of Microencapsulation · doi:10.3109/02652048.2014.932029 · Cited by 52 · see citing works

A novel approach to the pulmonary delivery of liposomes in dry powder form to eliminate the deleterious effects of milling

Desai, T. R., Wong, J. P., Hancock, R. E. W., & Finlay, W. H. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10021 · Cited by 51 · see citing works

Regional lung deposition of nebulized liposome-encapsulated ciprofloxacin

Finlay, W. H., & Wong, J. P. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00055-6 · Cited by 51 · see citing works

Inhaled Dry Powder Formulations for Treating Tuberculosis

Das, S. C., Tucker, I. G., & Stewart, P. (2015) · Current Drug Delivery · doi:10.2174/1567201811666140716123050 · Cited by 51 · see citing works

Crosslinked chitosan nanoparticle formulations for delivery from pressurized metered dose inhalers

Sharma, K., Somavarapu, S., Colombani, A., Govind, N., & Taylor, K. M. G. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.12.014 · Cited by 50 · see citing works

An Overview Of Tuberculosis Chemotherapy – A Literature Review

Sarkar, S., & Suresh, M. R. (2011) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j33591 · Cited by 49 · see citing works

Formulation and characterization of pyrazinamide polymeric nanoparticles for pulmonary tuberculosis: Efficiency for alveolar macrophage targeting

Varma, J. R., Kumar, T., Boddu, P., & Ratna, J. (2015) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.159602 · Cited by 49 · see citing works

Effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages

Chono, S., Kaneko, K., Yamamoto, E. M., Togami, K., & Morimoto, K. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639040903099744 · Cited by 49 · see citing works

In Vitro and In Vivo Evaluation of pH-Sensitive Hydrogels of Carboxymethyl Chitosan for Intestinal Delivery of Theophylline

Yadav, H. K. S., & Shivakumar, H. G. (2012) · ISRN Pharmaceutics · doi:10.5402/2012/763127 · Cited by 49 · see citing works

Oral Therapy Using Nanoparticle-Encapsulated Antituberculosis Drugs in Guinea Pigs Infected with Mycobacterium tuberculosis

Johnson, C. M., Pandey, R., Sharma, S., Khuller, G. K., Basaraba, R. J., Orme, I. M., & Lenaerts, A. J. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4335-4338.2005 · Cited by 49 · see citing works

Rifampicin-Loaded ‘Flower-Like’ Polymeric Micelles for Enhanced Oral Bioavailability in An Extemporaneous Liquid Fixed-Dose Combination with Isoniazid

Moretton, M. A., Höcht, C., Taira, C. A., & Sosnik, A. (2014) · Nanomedicine · doi:10.2217/nnm.13.154 · Cited by 48 · see citing works

Nanoparticle Encapsulated Lipopeptide Conjugate of Antitubercular Drug Isoniazid: In Vitro Intracellular Activity and in Vivo Efficacy in a Guinea Pig Model of Tuberculosis

Horváti, K., Bacsa, B., Kiss, É., Gyulai, G., Fodor, K., Balka, G., Rusvai, M., Szabó, E., Hudecz, F., & Bősze, S. E. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500476x · Cited by 47 · see citing works

Genipin crosslinked ethyl cellulose–chitosan complex microspheres for anti-tuberculosis delivery

Feng, H., Zhang, L., & Zhu, C. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.11.007 · Cited by 46 · see citing works

Model for the Deposition of Aerosol Particles in the Respiratory Tract of the Rat. I. Nonhygroscopic Particle Deposition

Schmid, O., Bolle, I., Harder, V., Karg, E. W., Takenaka, S., Schulz, H., & FERRON, G. A. (2008) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2008.0689 · Cited by 46 · see citing works

Aerosol properties and lung deposition

Ferron, G. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07081392 · Cited by 45 · see citing works

Pharmaceutical aerosols for the treatment and prevention of Tuberculosis

Hanif, S. N. M., & Garcia‐Contreras, L. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00118 · Cited by 45 · see citing works

Efficient Internalization and Intracellular Translocation of Inhaled Gold Nanoparticles in Rat Alveolar Macrophages

Takenaka, S., Möller, W., Semmler‐Behnke, M., Karg, E. W., Wenk, A., Schmid, O., Stoeger, T., Jennen, L., Aichler, M., Walch, A. K., et al. (2012) · Nanomedicine · doi:10.2217/nnm.11.152 · Cited by 45 · see citing works

Biological drug products : development and strategies

Wang, W., & Singh, M. (2014) · Wiley eBooks · Cited by 43 · see citing works

Evaluation of antitubercular drug‐loaded surfactants as inhalable drug‐delivery systems for pulmonary tuberculosis

Chimote, G., & Banerjee, R. (2009) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31959 · Cited by 41 · see citing works

Synthesis and characterization of pyruvate–isoniazid analogs and their copper complexes as potential ICL inhibitors

Shingnapurkar, D., Dandawate, P. R., Anson, C. E., Powell, A. K., Afrasiabi, Z., Sinn, E., Pandit, S., Swamy, K. V., Franzblau, S. G., & Padhyé, S. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.03.047 · Cited by 39 · see citing works

Aerosol droplet delivery of mesoporous silica nanoparticles: A strategy for respiratory-based therapeutics

Li, X., Xue, M., Raabe, O. G., Aaron, H. L., Eisen, E. A., Evans, J. E., Hayes, F. A., Inaga, S., Tagmount, A., Takeuchi, M., et al. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.03.007 · Cited by 39 · see citing works

Rehydrated Lyophilized Rifampicin-Loaded mPEG–DSPE Formulations for Nebulization

Abdulla, J. M. A., Tan, Y. T.-F., & Darwis, Y. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9428-6 · Cited by 36 · see citing works

Novel perspectives in the tuberculosis treatment: Administration of isoniazid through the skin

Caon, T., de Campos, C. E. M., Simões, C. M. O., & Silva, M. A. S. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.08.067 · Cited by 35 · see citing works

Aerosol vaccines for tuberculosis: A fine line between protection and pathology

Hokey, D. A., & Misra, A. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.09.007 · Cited by 35 · see citing works

Primary Mycobacterium tuberculosis complex cutaneous infection: report of two cases and literature review

Semaan, R., Traboulsi, R. S., & Kanj, S. S. (2008) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2008.03.002 · Cited by 34 · see citing works

Antimycobacterial activity of peptide conjugate of pyridopyrimidine derivative against Mycobacterium tuberculosis in a series of in vitro and in vivo models

Horváti, K., Bacsa, B., Szabó, N., Fodor, K., Balka, G., Rusvai, M., Kiss, É., Mező, G., Grolmusz, V. I., Vértessy, B. G., et al. (2015) · Tuberculosis · doi:10.1016/j.tube.2015.02.026 · Cited by 34 · see citing works

Formulation and In Vivo Evaluation of Effervescent Inhalable Carrier Particles for Pulmonary Delivery of Nanoparticles

Azarmi, S., Löbenberg, R., Roa, W., Tai, S., & Finlay, W. H. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802149079 · Cited by 33 · see citing works

Synthesis of Biodegradable Polymeric Nanoparticles and Their Controlled Drug Delivery for Tuberculosis

Malathi, S., & Balasubramanian, S. (2011) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2011.1244 · Cited by 33 · see citing works

Targeted Drug Delivery Systems for Lung Macrophages

Costa, A., Sarmento, B. F. C. C., & Seabra, V. (2014) · Current Drug Targets · doi:10.2174/1389450115666141114152713 · Cited by 32 · see citing works

Agglomerates of Ciprofloxacin Nanoparticles Yield Fine Dry Powder Aerosols

El-Gendy, N. A., Desai, V. M., & Berkland, C. J. (2010) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-010-9082-2 · Cited by 30 · see citing works

Effect of antitubercular drugs on dipalmitoylphosphatidylcholine monolayers: implications for drug loaded surfactants

Chimote, G., & Banerjee, R. (2004) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2004.10.003 · Cited by 27 · see citing works

Distribution of Effervescent Inhalable Nanoparticles After Pulmonary Delivery: an In Vivo Study

Alhallak, K., Sarfraz, M., Azarmi, S., Roa, W., Finlay, W. H., Rouleau, C., & Löbenberg, R. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.42 · Cited by 26 · see citing works

Lower cytotoxicity, high stability, and long-term antibacterial activity of a poly(methacrylic acid)/isoniazid/rifampin nanogel against multidrug-resistant intestinal Mycobacterium tuberculosis

Chen, T., Li, Q., Guo, L., Yu, L., Li, Z., Guo, H., Li, H., Zhao, M., Chen, L., Chen, X., et al. (2015) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.08.055 · Cited by 25 · see citing works

Cutaneous complication after BCG vaccination: Case report and review of the literature

Keijsers, R. R. M. C., Bovenschen, H. J., & Seyger, M. M. B. (2010) · Journal of Dermatological Treatment · doi:10.3109/09546634.2010.500325 · Cited by 24 · see citing works

Targeted drug delivery of Rifampicin to the lungs: formulation, characterization, and stability studies of preformed aerosolized liposome and in situ formed aerosolized liposome

Gaur, P. K., Mishra, S., Gupta, V. B., Rathod, M. S., Purohit, S., & Savla, B. A. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639040903410300 · Cited by 24 · see citing works

Model of the Deposition of Aerosol Particles in the Respiratory Tract of the Rat. II. Hygroscopic Particle Deposition

FERRON, G. A., Upadhyay, S., Zimmermann, R., & Karg, E. W. (2013) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2011.0965 · Cited by 23 · see citing works

Inhalable Antibiotics Manufactured Through Use of Near-Critical or Supercritical Fluids

Manion, J. R., Cape, S. P., McAdams, D. H., Rebits, L. G., Evans, S., & Sievers, R. E. (2012) · Aerosol Science and Technology · doi:10.1080/02786826.2011.634453 · Cited by 22 · see citing works

In Vitro and In Vivo Activities of Acylated Derivatives of Isoniazid Against Mycobacterium Tuberculosis

Hearn, M. J., & Cynamon, M. H. (2003) · Drug design and discovery · doi:10.1080/10559610390450705 · Cited by 22 · see citing works

The devil’s advocacy: When and why inhaled therapies for tuberculosis may not work

Yadav, A. B., Singh, A. K., Verma, R. K., Mohan, M., Agrawal, A. K., & Misra, A. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.10.001 · Cited by 20 · see citing works

Triggered release of ciprofloxacin from nanostructured agglomerated vesicles.

Bhavane, R. C., Karathanasis, E., & Annapragada, A. (2007) · PubMed Central · Cited by 19 · see citing works

In Vitro and In Vivo Activities of Acylated Derivatives of Isoniazid Against Mycobacterium Tuberculosis

Hearn, M. J., & Cynamon, M. H. (2003) · Drug design and discovery · doi:10.3109/10559610390450705 · Cited by 19 · see citing works

Lactose-Conjugated PLGA Nanoparticles for Enhanced Delivery of Rifampicin to the Lung for Effective Treatment of Pulmonary Tuberculosis.

Jain, S., Gupta, Y., Ramalingam, L., Jain, A., Jain, A., Khare, P., & Bhargava, D. (2010) · PubMed · Cited by 18 · see citing works

Fabrication of inhalable spore like pharmaceutical particles for deep lung deposition

Shen, Z., Chen, W., Jugade, N., Gao, L., Glover, W., Shen, J., Yun, J., & Chen, J. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.044 · Cited by 17 · see citing works

Alternatives to conventional suspensions for pulmonary drug delivery by nebulisers: A review

Amani, A., Amini, M. A., Ali, H. S. M., & York, P. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22665 · Cited by 14 · see citing works

Morphology and bilayer integrity of small liposomes during aerosol generation by air-jet nebulisation

Chattopadhyay, S., Ehrman, S. H., Bellare, J. R., & Venkataraman, C. (2012) · Journal of Nanoparticle Research · doi:10.1007/s11051-012-0779-7 · Cited by 11 · see citing works

Structure and function of the tuberculous lung: Considerations for inhaled therapies

Sethi, T., & Agrawal, A. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.08.008 · Cited by 8 · see citing works

Cutaneous tuberculosis caused by isoniazid-resistant Mycobacterium tuberculosis

Gharabaghi, M. A. (2012) · BMJ Case Reports · doi:10.1136/bcr-2012-006253 · Cited by 5 · see citing works

Nanotechnology approaches for global infectious diseases

Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00866-8 · Cited by 520 · see citing works

Recent Advances in Polymeric Nanoparticle-Encapsulated Drugs against Intracellular Infections

Sánchez, A., Mejía, S. P., & Orozco, J. (2020) · Molecules · doi:10.3390/molecules25163760 · Cited by 161 · see citing works

Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis

Vieira, A. C. C., Chaves, L. L., Pinheiro, S., Pinto, S. F. T., Pinheiro, M., Lima, S. A. C., Ferreira, D., Sarmento, B. F. C. C., & Reis, S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.11.071 · Cited by 148 · see citing works

Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient?

Forest, V., & Pourchez, J. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114173 · Cited by 131 · see citing works

Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles

Costa-Gouveia, J., Pancani, E., Jouny, S., Machelart, A., Delorme, V., Salzano, G., Iantomasi, R., Piveteau, C., Queval, C. J., Song, O., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05453-3 · Cited by 102 · see citing works

Mannosylated solid lipid nanoparticles for the selective delivery of rifampicin to macrophages

Vieira, A. C. C., Chaves, L. L., Pinheiro, M., Lima, S. A. C., Ferreira, D., Sarmento, B. F. C. C., & Reis, S. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1434186 · Cited by 92 · see citing works

Advanced drug delivery and therapeutic strategies for tuberculosis treatment

Nair, A., Greeny, A., Nandan, A., Sah, R. K., Jose, A., Dyawanapelly, S., Junnuthula, V., Athira, K. V., & Sadanandan, P. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02156-y · Cited by 99 · see citing works

Targeted Macrophages Delivery of rifampicin-loaded Lipid Nanoparticles to Improve Tuberculosis Treatment

Vieira, A. C. C., Magalhães, J., Rocha, S., Cardoso, M. S., Santos, S. G., Borges, M. C., Pinheiro, M., & Reis, S. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0248 · Cited by 88 · see citing works

Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy

Cruz-Teran, C. A., Tiruthani, K., McSweeney, M. D., Ma, A. D., Pickles, R., & Lai, S. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.004 · Cited by 77 · see citing works

Nanotechnology‐Based Targeted Drug Delivery: An Emerging Tool to Overcome Tuberculosis

Baranyai, Z., Soria‐Carrera, H., Alleva, M., Millán-Placer, A. C., Lucía, A., Martín‐Rapún, R., Aínsa, J. A., & de la Fuente, J. M. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000113 · Cited by 85 · see citing works

Fungal Contamination of Building Materials and the Aerosolization of Particles and Toxins in Indoor Air and Their Associated Risks to Health: A Review

Hallak, M. A., Verdier, T., Bertron, A., Roques, C. G., & Bailly, J. (2023) · Toxins · doi:10.3390/toxins15030175 · Cited by 76 · see citing works

Molecular and cellular cues governing nanomaterial–mucosae interactions: from nanomedicine to nanotoxicology

das Neves, J., Arzi, R. S., & Sosnik, A. (2020) · Chemical Society Reviews · doi:10.1039/c8cs00948a · Cited by 72 · see citing works

Inhalation of Microplastics—A Toxicological Complexity

Borgatta, M., & Breider, F. (2024) · Toxics · doi:10.3390/toxics12050358 · Cited by 75 · see citing works

How can nanoparticles contribute to antituberculosis therapy?

Costa-Gouveia, J., Aínsa, J. A., Brodin, P. M., & Lucía, A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.01.011 · Cited by 68 · see citing works

Advancements in Chitosan-Based Nanoparticles for Pulmonary Drug Delivery

Zacaron, T. M., Silva, M. L. S. E., Costa, M. P., Silva, D. M. E., Silva, A. C., Apolônio, A. C. M., Fabri, R. L., Pittella, F., Rocha, H. V. A., & Tavares, G. D. (2023) · Polymers · doi:10.3390/polym15183849 · Cited by 67 · see citing works

Antibodies and associates: Partners in targeted drug delivery

Kennedy, P. J., Oliveíra, C., Granja, P. L., & Sarmento, B. F. C. C. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.03.004 · Cited by 68 · see citing works

Potential of dry powder inhalers for tuberculosis therapy: facts, fidelity and future

Mehta, P. P., Bothiraja, C., Kadam, S. S., & Pawar, A. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1513938 · Cited by 65 · see citing works

Modulating lung immune cells by pulmonary delivery of antigen-specific nanoparticles to treat autoimmune disease

Saito, E., Gurczynski, S. J., Kramer, K. R., Wilke, C. A., Miller, S. D., Moore, B. B., & Shea, L. D. (2020) · Science Advances · doi:10.1126/sciadv.abc9317 · Cited by 59 · see citing works

Sericin-chitosan doped maleate gellan gum nanocomposites for effective cell damage in Mycobacterium tuberculosis

Mehnath, S., Sithika, M. A. A., Arjama, M., Rajan, M., Praphakar, R. A., & Jeyaraj, M. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.10.167 · Cited by 58 · see citing works

Encapsulation of Isoniazid-conjugated Phthalocyanine-In-Cyclodextrin-In-Liposomes Using Heating Method

Nkanga, C. I., & Krause, R. W. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-47991-y · Cited by 55 · see citing works

Engineered drug delivery devices to address Global Health challenges

Sadeghi, I., Byrne, J. D., Shakur, R., & Langer, R. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.01.035 · Cited by 50 · see citing works

Mesoporous Silica Nanoparticles as Drug Delivery Systems

Benkő, F., Kristó, K., & Sovány, T. (2025) · Pharmaceuticals · doi:10.3390/ph18091392 · Cited by 48 · see citing works

Recent advances in gold nanoparticles-based biosensors for tuberculosis determination

Eivazzadeh‐Keihan, R., Saadatidizaji, Z., Mahdavi, M. R., Maleki, A. R., Irani, M., & Zare, I. (2024) · Talanta · doi:10.1016/j.talanta.2024.126099 · Cited by 46 · see citing works

Targeting pulmonary tuberculosis using nanocarrier-based dry powder inhalation: current status and futuristic need

Patil, T. S., Deshpande, A. S., Deshpande, S., & Shende, P. K. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1455842 · Cited by 46 · see citing works

Lipid nanoparticles coated with chitosan using a one-step association method to target rifampicin to alveolar macrophages

Vieira, A. C. C., Chaves, L. L., Pinheiro, M., Lima, S. A. C., Neto, P. J. R., Ferreira, D., Sarmento, B. F. C. C., & Reis, S. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116978 · Cited by 42 · see citing works

Surface Modification of Nanoparticles: Methods and Applications

Moku, G., Gopalsamuthiram, V., Hoye, T. R., & Panyam, J. (2019) · doi:10.1002/9783527819249.ch11 · Cited by 42 · see citing works

Prevention and potential remedies for antibiotic resistance: current research and future prospects

Khan, R. T., Sharma, V., Khan, S. S., Rasool, S., Singh, S., Rai, A. K., Rustagi, S., Shreaz, S., Negi, R., Kour, D., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1455759 · Cited by 40 · see citing works

Intratracheal Delivery of Nano- and Microparticles and Hyperpolarized Gases

Wang, H., Wu, L., & Sun, X. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.11.036 · Cited by 37 · see citing works

Rifampicin Nanoformulation Enhances Treatment of Tuberculosis in Zebrafish

Trousil, J., Syrová, Z., Dal, N. K., Rak, D., Konefał, R., Pavlová, E., Matějková, J., Cmarko, D., Kubíčková, P., Pavliš, O., et al. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b00214 · Cited by 36 · see citing works

Stabilizing silica nanoparticles in hydrogels: impact on storage and polydispersity

Giovannini, G., Kunc, F., Piras, C. C., Stránik, O., Edwards, A. A., Hall, A. J., & Gubala, V. (2017) · RSC Advances · doi:10.1039/c7ra02427d · Cited by 35 · see citing works

In vitro and in vivo antitubercular activity of benzothiazinone-loaded human serum albumin nanocarriers designed for inhalation

Patel, A., Redinger, N., Richter, A., Woods, A., Neumann, P., Keegan, G. M., Childerhouse, N., Imming, P., Schaible, U. E., Forbes, B., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.022 · Cited by 34 · see citing works

Current advances in drug delivery of nanoparticles for respiratory disease treatment

de Menezes, B. R. C., Rodrigues, K. F., Schatkoski, V. M., Pereira, R. M., Ribas, R. G., Montanheiro, T. L. D. A., & Thim, G. P. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb01783c · Cited by 34 · see citing works

Biodegradable micro-sized discoidal polymeric particles for lung-targeted delivery system

Park, J. Y., Park, S.-H., Lee, T. S., Hwang, Y. H., Kim, J. Y., Kang, W. J., & Key, J. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119331 · Cited by 33 · see citing works

Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages

Gairola, A., Benjamin, A. B., Weatherston, J. D., Cirillo, J. D., & Wu, H. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202100193 · Cited by 31 · see citing works

Formulation and clinical translation of inhalable nanomedicines for the treatment and prevention of pulmonary infectious diseases

Ahmed, R., Tewes, F., Aucamp, M. E., & Dube, A. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01861-5 · Cited by 34 · see citing works

Spray-Dried, Nanoencapsulated, Multi-Drug Anti-Tuberculosis Therapy Aimed at Once Weekly Administration for the Duration of Treatment

Kalombo, L., Lemmer, Y., Semete‐Makokotlela, B., Ramalapa, B., Nkuna, P., Booysen, L., Naidoo, S., Hayeshi, R. K., Verschoor, J. A., & Swai, H. (2019) · Nanomaterials · doi:10.3390/nano9081167 · Cited by 28 · see citing works

Treatments of Mycobacterium tuberculosis and Toxoplasma gondii with Selenium Nanoparticles

Ifijen, I. H., Atoe, B., Ekun, R. O., Ighodaro, A., & Odiachi, I. J. (2023) · BioNanoScience · doi:10.1007/s12668-023-01059-4 · Cited by 28 · see citing works

Role of morphology and chemical composition of PM for particle deposition in human respiratory system: A case study over megacity-Delhi

Fatima, S., Mishra, S. K., Kumar, U., Ahlawat, A., Dabodiya, T. S., & Khosla, D. (2022) · Urban Climate · doi:10.1016/j.uclim.2022.101344 · Cited by 27 · see citing works

Lessons from the history of inorganic nanoparticles for inhalable diagnostics and therapeutics

Uskoković, V. (2023) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2023.102903 · Cited by 28 · see citing works

Commercial utilities and future perspective of nanomedicines

Malviya, R., Fuloria, S., Verma, S., Subramaniyan, V., Sathasivam, K. V., Kumarasamy, V., Darnal, H. K., Vellasamy, S., Meenakshi, D. U., Yadav, S., et al. (2021) · PeerJ · doi:10.7717/peerj.12392 · Cited by 26 · see citing works

Preparation, characterization, and in-vitro cytotoxicity of nanoliposomes loaded with anti-tubercular drugs and TGF-β1 siRNA for improving spinal tuberculosis therapy

Yang, Z., Lou, C., Wang, X., Wang, C., Shi, Z., & Niu, N. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07791-8 · Cited by 25 · see citing works

Pharmacokinetics and in vivo distribution of optimized PLGA nanoparticles for pulmonary delivery of levofloxacin

Shah, S. R., Prajapati, H. R., Sheth, D. B., Gondaliya, E. M., Vyas, A. J., Soniwala, M. M., & Chavda, J. R. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13275 · Cited by 25 · see citing works

The (re)emergence of aerosol delivery: Treatment of pulmonary diseases and its clinical challenges

Ghanem, R., Youf, R., Haute, T., Buin, X., Riool, M., Pourchez, J., & Montier, T. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.017 · Cited by 24 · see citing works

Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles

Khoza, L. J., Kumar, P., Dube, A., Demana, P. H., & Choonara, Y. E. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121893 · Cited by 24 · see citing works

Lipid Nanoparticles Biocompatibility and Cellular Uptake in A 3D Human Lung Model

Magalhães, J., Pinheiro, M., Drašler, B., Septiadi, D., Petri‐Fink, A., Santos, S. G., Rothen‐Rutishauser, B., & Reis, S. (2019) · Nanomedicine · doi:10.2217/nnm-2019-0256 · Cited by 24 · see citing works

Nano-based carriers for pulmonary drug delivery: A review on the available drug delivery applications and toxicity issues

Siafaka, P. I., Bülbül, E. Ö., Miliotou, Α. N., Karantas, I. D., Okur, M. E., & Okur, N. Ü. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105381 · Cited by 23 · see citing works

Selective drug deposition in lungs through pulmonary drug delivery system for effective management of drug-resistant TB

Sankhe, K., Khan, T., Bhavsar, C., Momin, M., & Omri, A. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1609937 · Cited by 18 · see citing works

Fucosylated lipid nanocarriers loaded with antibiotics efficiently inhibit mycobacterial propagation in human myeloid cells

Durán, V., Grabski, E., Hozsa, C., Becker, J., Yasar, H., Monteiro, J. T., Costa, B., Koller, N., Lueder, Y., Wiegmann, B., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.04.012 · Cited by 23 · see citing works

Inhaled biologics for respiratory diseases: clinical potential and emerging technologies

Shaibie, N. A., Faizal, N. D. F. M., Buang, F., Srichana, T., & Amin, M. C. I. M. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01909-6 · Cited by 22 · see citing works

In silico identification and synthesis of a multi-drug loaded MOF for treating tuberculosis

Acharya, A. P., Sezginel, K. B., Gideon, H. P., Greene, A. C., Lawson, H., Inamdar, S., Tang, Y., Fraser, A. J., Patel, K. V., Liu, C., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.10.024 · Cited by 22 · see citing works

In vitro delivery efficiencies of nebulizers for different breathing patterns

Park, H. M., Chang, K. H., Moon, S.-H., Park, B. J., Yoo, S. K., & Nam, K. C. (2021) · BioMedical Engineering OnLine · doi:10.1186/s12938-021-00895-3 · Cited by 20 · see citing works

Isoniazid—Loaded Albumin Nanoparticles: Taguchi Optimization Method

Tazhbayev, Y. M., Galiyeva, A. R., Zhumagaliyeva, T., Burkeyev, M., & Karimova, B. (2021) · Polymers · doi:10.3390/polym13213808 · Cited by 20 · see citing works

Π-Π interactions stabilize PeptoMicelle-based formulations of Pretomanid derivatives leading to promising therapy against tuberculosis in zebrafish and mouse models

Dal, N. K., Schäfer, G. G., Thompson, A. M., Schmitt, S., Redinger, N., Alonso‐Rodríguez, N., Johann, K., Ojong, J., Wohlmann, J., Best, A., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.037 · Cited by 20 · see citing works

Cure of tuberculosis using nanotechnology: An overview

Kerry, R. G., Gouda, S., Sil, B., Das, G., Shin, H., Ghodake, G. S., & Patra, J. K. (2018) · The Journal of Microbiology · doi:10.1007/s12275-018-7414-y · Cited by 20 · see citing works

Optimization of Polylactide-Co-Glycolide-Rifampicin Nanoparticle Synthesis, In Vitro Study of Mucoadhesion and Drug Release

Yessentayeva, N. A., Galiyeva, A. R., Daribay, A. T., Sadyrbekov, D. T., Moustafine, R. I., & Tazhbayev, Y. M. (2024) · Polymers · doi:10.3390/polym16172466 · Cited by 17 · see citing works

Polystyrene Micro(nano)plastic-Induced Ca 2+ Disorder Activates Endoplasmic Reticulum and Mitochondrial Signaling Pathways to Synergistically Promote Apoptosis in Human Lung Cells

He, Q., Zhang, Y., Zhu, L., Peng, Z., Liu, M., Hou, S., Pei, C., Yin, D., Zhang, S., & Cai, Z. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c00380 · Cited by 17 · see citing works

An all-in-one nanomaterial derived from rGO-MoS 2 for photo/chemotherapy of tuberculosis

Mehnath, S., Karuppannan, C., & Jeyaraj, M. (2022) · New Journal of Chemistry · doi:10.1039/d1nj03549e · Cited by 16 · see citing works

Enhancement of Antimycobacterial Activity of Rifampicin Using Mannose-Anchored Lipid Nanoparticles against Intramacrophage Mycobacteria

Mistry, N., Bandyopadhyaya, R., & Mehra, S. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00796 · Cited by 15 · see citing works

In Vitro Evaluation of Colistin Conjugated with Chitosan-Capped Gold Nanoparticles as a Possible Formulation Applied in a Metered-Dose Inhaler

Changsan, N., Atipairin, A., Muenraya, P., Sritharadol, R., Srichana, T., Balekar, N., & Sawatdee, S. (2024) · Antibiotics · doi:10.3390/antibiotics13070630 · Cited by 15 · see citing works

Current trends in inhaled pharmaceuticals: challenges and opportunities in respiratory infections treatment

Shah, K. A., Razzaq, A., Dormocara, A., You, B., Elbehairi, S. E. I., Shati, A. A., Alfaifi, M. Y., Iqbal, H., & Cui, J.-H. (2025) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-025-00729-7 · Cited by 15 · see citing works

Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis?

Abbadi, B. L., Rodrigues-Junior, V. S., Dadda, A. D. S., Pissinate, K., Villela, A. D., Campos, M. M., Lopes, L. G. D. F., Bizarro, C. V., Machado, P., Sousa, E. H. S., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00880 · Cited by 15 · see citing works

Bridging micro/nano-platform and airway allergy intervention

Sun, M., Teng, Z., Fan, P., Chen, X., & Liu, Y. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.040 · Cited by 13 · see citing works

Lipopolysaccharide Polyelectrolyte Complex for Oral Delivery of an Anti-tubercular Drug

Sumaila, M., Ramburrun, P., Kumar, P., Choonara, Y. E., & Pillay, V. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1310-6 · Cited by 13 · see citing works

Insights into therapeutic liquid mixtures and formulations towards tuberculosis therapy

Santos, F., Pires, D., Anes, E., & Duarte, A. R. C. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122862 · Cited by 11 · see citing works

Development and Optimization of Inhalable Levofloxacin Nanoparticles for The Treatment of Tuberculosis

Shah, S. R., Ghetiya, R., Soniwala, M. M., & Chavda, J. R. (2020) · Current Drug Delivery · doi:10.2174/1567201817999201103194626 · Cited by 12 · see citing works

Redefining Therapies for Drug‐Resistant Tuberculosis: Synergistic Effects of Antimicrobial Peptides, Nanotechnology, and Computational Design

Canales, C. S. C., Cazorla, J. I. M., Cazorla, R. M. M., dos Santos, A. M., Duarte, J. L., Nunes, L. O. C., Reis, T. C., Salvador, L. C., Santos‐Filho, N. A., Sábio, R. M., et al. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202503964 · Cited by 11 · see citing works

Chitosan functionalization of metal- and carbon-based nanomaterials as an approach toward sustainability tomorrow

Maluin, F. N., & Katas, H. (2022) · Nanotoxicology · doi:10.1080/17435390.2022.2090025 · Cited by 11 · see citing works

Advances and Opportunities In Nanoimaging Agents for the Diagnosis of Inflammatory Lung Diseases

Masanam, H. B., Perumal, G., Krishnan, S., Singh, S. K., Jha, N. K., Chellappan, D. K., Dua, K., Gupta, P. K., & Narasimhan, A. K. (2022) · Nanomedicine · doi:10.2217/nnm-2021-0427 · Cited by 11 · see citing works

Automated SEM/EDX imaging for the in-depth characterization of non-exhaust traffic emissions from the Munich subway system

Neukirchen, C., Meiners, T., Bendl, J., Zimmermann, R., & Adam, T. W. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.170008 · Cited by 11 · see citing works

Appraisal of fluoroquinolone-loaded carubinose-linked hybrid nanoparticles for glycotargeting to alveolar macrophages

Maurya, P., Saklani, R., Singh, S., Nisha, R., Pal, R. R., Mishra, N., Singh, P., Kumar, A., Chourasia, M. K., & Saraf, S. A. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01055-9 · Cited by 11 · see citing works

Drug Nanocrystals: A Delivery Channel for Antiviral Therapies

Chaturvedi, A., Sharma, S. K., & Shukla, R. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02754-5 · Cited by 10 · see citing works

Bio-Analytical Method Development for Estimation of Levofloxacin: Application in Estimation of Drug in Nano-formulations and Pharmacokinetic Studies

Maurya, P., Kumar, A., Singh, S., Nisha, R., Pal, R. R., Chourasia, M. K., & Saraf, S. A. (2021) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.55.3s.189 · Cited by 9 · see citing works

Immunomodulating polyorganophosphazene-arginine layered liposome antibiotic delivery vehicle against pulmonary tuberculosis

Mehnath, S., Rajan, M., & Jeyaraj, M. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102856 · Cited by 9 · see citing works

INFLUENCE OF PARTICLE SIZE AND PARTICLE DEPOSITION OF INHALED MEDICATION IN LUNG DISEASE: A COMREHENSIVE REVIEW

Dudhat, K. R., & Patel, H. V. (2022) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2022.140119 · Cited by 8 · see citing works

Nano-engineered solutions for extensively drug-resistant tuberculosis (XDR-TB): A novel nanomedicine

Singh, D., Krishna, V. S., Kumari, N., Banerjee, A., & Kapoor, P. (2024) · Nano-Structures & Nano-Objects · doi:10.1016/j.nanoso.2024.101390 · Cited by 8 · see citing works

Exploring the Potential of PLGA Nanoparticles for Enhancing Pulmonary Drug Delivery

Costa, M. P., Abdu, J. O. C., de Moura, M. F. C. S., Silva, A. C., Zacaron, T. M., de Paiva, M. R. B., Fabri, R. L., Pittella, F., Perrone, Í. T., & Tavares, G. D. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00118 · Cited by 9 · see citing works

Liposomal drug delivery system for lung diseases: Recent advancement and future perspectives

Bashyal, S., Suwal, N., Thapa, R., Bagale, L. R., Sugandhi, V. V., Subedi, S., Idrees, S., Panth, N., Elwakil, B. H., El-Khatib, M., et al. (2025) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2025.102855 · Cited by 8 · see citing works

Pyrazinoic acid-Poly(malic acid) biodegradable nanoconjugate for efficient intracellular delivery

Carneiro, S. P., Moine, L., Tessier, B., Nicolas, V., dos Santos, O. D. H., & Fattal, E. (2019) · Precision Nanomedicine · doi:10.33218/prnano2(3).190523.1 · Cited by 8 · see citing works

Supramolecular Polymers in Nanomedicine

Homyak, C., Anson, F., & Thayumanavan, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12566-1 · Cited by 8 · see citing works

Nanotechnology as a potential tool against drug- and multidrug-resistant tuberculosis

Pérez-Martínez, D. E., & Zenteno‐Cuevas, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819811-7.00003-5 · Cited by 8 · see citing works

Intranasal and inhaled delivery systems for targeting circadian dysfunction in neurodegenerative disorders, perspective and future outlook

Ryan, R. C., Leslie, M. N., He, P., Young, P. M., Hoyos, C. M., Ong, H. X., & Traini, D. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115575 · Cited by 9 · see citing works

Antimycobacterial compound of chitosan and ethambutol: ultrastructural biological evaluation in vitro against Mycobacterium tuberculosis

Oliveira, M. E. F. A. G., Silva, Y. J. A., de Azevedo, L. A., Linhares, L. D. A., Montenegro, L. M. L., Alves, S., & Amorim, R. V. S. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11690-4 · Cited by 7 · see citing works

Synthesis, Characterizations, and Use of O-Stearoyl Mannose Ligand-Engineered Lipid Nanoarchitectonics for Alveolar Macrophage Targeting

Thalla, M., Gangasani, J. K., Saha, P., Ponneganti, S., Borkar, R. M., Naidu, V. G. M., Murty, U. S. N., & Banerjee, S. (2020) · Assay and Drug Development Technologies · doi:10.1089/adt.2020.999 · Cited by 7 · see citing works

Design of Pyrene–Fatty Acid Conjugates for Real-Time Monitoring of Drug Delivery and Controllability of Drug Release

Hayashi, K., Mitsuyoshi, Y., Kamei, T., Shimanouchi, T., Suga, K., Okamoto, Y., Nakamura, H., & Umakoshi, H. (2018) · ACS Omega · doi:10.1021/acsomega.7b02061 · Cited by 7 · see citing works

Progress in Treatment and Diagnostics of Infectious Disease with Polymers

Patra, S., Pareek, D., Gupta, P. S., Wasnik, K., Singh, G., Yadav, D. D., Mastai, Y., & Paik, P. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00528 · Cited by 6 · see citing works

Preparation and characterization of slow dissolving linezolid salts for direct pulmonary delivery

Mori, D., jaroli, T., Dudhat, K. R., Vaishnav, D. J., Parmar, R., Kotadiya, N., Bhalodiya, M., & Pashavan, C. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103741 · Cited by 6 · see citing works

Synthesis and characterization of isoniazid immobilized polylactide-co-glycolide nanoparticles

Tazhbayev, Y. M., Galiyeva, A. R., Zhumagaliyeva, T., Burkeyev, M., Kazhmuratova, A. T., Zhakupbekova, E. Z., Zhaparova, L. Z., & Bakibayev, A. A. (2021) · Bulletin of the Karaganda University Chemistry series · doi:10.31489/2021ch1/61-70 · Cited by 6 · see citing works

Phytomedicinal flavonoid loaded phospholipid sheathed lipidic nano-carriers as a platform with boosted oral anti-mycobacterium activity

Elnady, R. E., Amin, M. M., & Zakaria, M. Y. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104775 · Cited by 5 · see citing works

Treatment of Tuberculosis in Nano Era: Recent Avenues

Rathi, R., Nagpal, M., Kaur, M., Ballouria, P., Dutta, R., Aggarwal, G., & Arora, S. (2022) · Current Bioactive Compounds · doi:10.2174/1573407218666220127085637 · Cited by 5 · see citing works

Nebulized, macrophage-targeted, Linezolid-loaded lipid carriers for intracellular treatment of tubercular infections – In vitro/in vivo study

Makled, S., Nafee, N. A., Okasha, H. A. S., & Boraie, N. A. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106202 · Cited by 4 · see citing works

Phase 1 and preclinical studies reveal safety, pharmacokinetics, and efficacy of intranasal delivery of the influenza antibody CR9114

Beukenhorst, A. L., Rogiers, R., Rice, K. L., Booth, G. C., Haasnoot, J., Nkolola, J. P., Ayala, J., Wang, L., Jülg, B. D., Pastini, A. K., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adz1580 · Cited by 4 · see citing works

Preparation of antibody-loaded protein microbeads for pulmonary delivery via Shirasu porous glass membrane emulsification and freeze drying

Lee, J. C., Lee, E. C., Lee, Y. N., Hada, S., Lee, E. H., Kim, N. A., Kim, K. H., & Jeong, S. H. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105600 · Cited by 4 · see citing works

Nano-Medicine for Treatment of Tuberculosis, Promising Approaches Against Antimicrobial Resistance

Mobed, A., Alivirdiloo, V., Gholami, S., Moshari, A., Mousavizade, A., Naderian, R., & Ghazi, F. (2024) · Current Microbiology · doi:10.1007/s00284-024-03853-z · Cited by 4 · see citing works

Rifampicin‐Loaded Nano‐in‐Microparticles (Trojan Particles) as a Pulmonary Delivery System for Tuberculosis Treatment

Pham, D., Luong, V., Huynh, T. T. N., Huynh, D. T. M., & Phạm, D. T. (2024) · ChemNanoMat · doi:10.1002/cnma.202400296 · Cited by 3 · see citing works

Encapsulation of Isoniazid in Polylactide-Co-Glycolide Nanoparticles by Nanoprecipitation

Galiyeva, A. R., Tazhbayev, Y. M., Zhumagaliyeva, T., & Daribay, A. T. (2022) · Bulletin of the Karaganda University Chemistry series · doi:10.31489/2022ch3/3-22-17 · Cited by 3 · see citing works

Nano‐Based Drug Delivery in Eliminating Tuberculosis

Gopinathan, A., Naik, S. S., Leela, K. V., & Ravi, S. (2023) · doi:10.1002/9781394167708.ch11 · Cited by 3 · see citing works

Synthesis and Investigation of Albumin Nanoparticles Loaded With Anti‐Tuberculosis Drug Isoniazid

Galiyeva, A. R., Tazhbayev, Y. M., Zhumagaliyeva, T., Karimova, B., Tabriz, N., & Khutoryanskiy, V. V. (2025) · Biopolymers · doi:10.1002/bip.70036 · Cited by 2 · see citing works

Human lung cell cytotoxicity of antibacterial-loaded silica nanoparticles

Mebert, A. M., Evelson, P., Desimone, M. F., & Maysinger, D. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105298 · Cited by 2 · see citing works

Inhalable bioadhesive barrier for lung protection and clearance of fine particulate matter

Liu, J., Yan, N., Liu, M., Shen, M., Hu, S., Mei, X., Zhu, D., Zhang, S., & Cheng, K. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.03.045 · Cited by 1 · see citing works

Mucoadhesive Chitosan–Gellan Gum Nanoparticles for Rifampicin Delivery: Taguchi Optimization and In Vitro Release Behavior

Cheung, S.-Y., Galiyeva, A. R., Tazhbayev, Y. M., Zhumagaliyeva, T., Bardadym, Y. V., & Aseyev, V. O. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18050627 · Cited by 1 · see citing works

New Approaches from Nanomedicine and Pulmonary Drug Delivery for the Treatment of Tuberculosis

Magalhães, J., Vieira, A. C. C., Pinto, S. F. T., Pinheiro, S., Granja, A., Santos, S. G., Pinheiro, M., & Reis, S. (2018) · doi:10.1201/9781351207355-8 · Cited by 2 · see citing works

Oral Administration of Nanoparticles-Based TB Drugs

Magalhães, J., Vieira, A. C. C., Santos, S. G., Pinheiro, M., & Reis, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52725-5.00016-2 · Cited by 13 · see citing works

Nanoparticles: A Novel Pulmonary Drug Delivery System for Tuberculosis

Reddy, N. J. G. (2013)

A review on recent advances in nanomedicines for the treatment of pulmonary tuberculosis

Chaudhary, K. R., Puri, V., Singh, A., & Singh, C. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.103069 · Cited by 25 · see citing works

Nanotechnology-enabled Drug Delivery Systems for Tuberculosis: A Paradigm Shift in Treatment

Varadarajan, N., Annes, T., Punniyakotti, S., Gopinath, S., Solaimuthu, H., & Balan, M. (2026) · Drug Delivery Letters · doi:10.2174/0122103031428690260330053221